NUZ-001 has shown it promotes healthy and viable brain tissues, potentially demonstrating its use to treat Alzheimer’s and ...

Neurizon Therapeutics Ltd (ASX:NUZ) has yielded positive results from an independent study – conducted in collaboration with ...

Mach 7 and Universal Biosensors have announced their CEOs will depart, while changes at the top are likely at other biotechs.

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Neurizon Therapeutics Limited (NUZ). However, you won't necessarily see their names in the ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

Neurizon Therapeutics (ASX: NUZ) has reported positive results from an independent study into the effects of neuroprotective ...

Neurizon Therapeutics' (ASX:NUZ) lead drug candidate has demonstrated positive results in the latest round of testing with ...

NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...

Financial Health for Neurizon Therapeutics is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets. Loading view ...

A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a ...

The ASX 200 has bounced back so far on Friday despite Wall Street ticking lower. Ressie and energy stocks are showing the way. And that seems to be the case so far today for the ASX 200, which has ...